LINFOMAS Y TRASPLANTES

Foto de LINFOMAS Y TRASPLANTES

Foto de University Hospital Heidelberg

University Hospital Heidelberg

Heidelberg, Alemania

Publikationen in Zusammenarbeit mit Forschern von University Hospital Heidelberg (5)

2024

Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: A prospective study
Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 1

2021

Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT
Bone Marrow Transplantation, Vol. 56, Núm. 2, pp. 481-491

2018

Ibrutinib versus temsirolimus: 3-year follow-up of patients with previously treated mantle cell lymphoma from the phase 3, international, randomized, open-label RAY study
Leukemia, Vol. 32, Núm. 8, pp. 1799-1803

2016

Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: An international, randomised, open-label, phase 3 study
The Lancet, Vol. 387, Núm. 10020, pp. 770-778

2015

Comparison of upfront tandem autologous-allogeneic transplantation versus reduced intensity allogeneic transplantation for multiple myeloma
Bone Marrow Transplantation, Vol. 50, Núm. 6, pp. 802-807